Coriolis Pharma
Coriolis Pharma offers Biophysical characterization, formulation and stability of biologics. Services should be matched to the intended study and assay requirements.
Corporate information
- Company entity
- Coriolis Pharma
- Headquarters / principal office
- Headquarters city not independently verified; see the country/network tags.
- Founded
- 2008 ↗
- Ownership / capital status
- PrivatePrivately held; latest independently attributable funding amount not verified ↗
- Official corporate reference
- https://coriolis-pharma.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
- Latest financing / award identified
- 2023-10-16 · 成长投资 · 未披露 ↗
KKR Health Care Strategic Growth Fund II投资，轮次名称及金额未披露。
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Coriolis Pharma offers Biophysical characterization, formulation and stability of biologics. Services should be matched to the intended study and assay requirements.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Formulation Development Services
- Coriolis Pharma — LinkedIn
- Coriolis官方历史：2008年成立
- Coriolis strategic growth partnership with KKR and Frontier Biosolutions